BackJW Pharmaceutical Overview

JW Pharmaceutical Receivables

JW Pharmaceutical's receivables is $120B.

Get informed when a big investor buys or sells

+ Follow
Receivables
$117.81B
↓ 5.97% YoYΔ $-7.47B vs prior year quarter

Peer trimmed avg / median

Loading

JW Pharmaceutical Receivables History

Loading

JW Pharmaceutical vs. peers: Receivables Comparison

Loading

JW Pharmaceutical Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

JW Pharmaceutical (001067.KS) FAQ

As of the most recent data (June 2026), 001067.KS shows a receivables of $120B. That compares with $130B in the prior-year period — down 6.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 001067.KS's receivables is now $120B (was $130B) — a 6.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether JW Pharmaceutical is outperforming or lagging.

Tracking 001067.KS's receivables over time shows whether JW Pharmaceutical is scaling, shrinking, or reshaping that part of the business. The current reading is $120B That compares with $130B in the prior-year period — down 6.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has JW Pharmaceutical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $120B) with ownership activity and broader fundamentals.